Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 7Active not recruiting 6Recruiting 5Not yet recruiting 2Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

High Grade Anal Canal Intraepithelial Neoplasia 1

Interventions

Cyclophosphamide 390Carboplatin 343Gemcitabine 331pembrolizumab 330Cisplatin 327Paclitaxel 295Radiotherapy 292Docetaxel 286Bevacizumab 249Rituximab 233Capecitabine 222Nivolumab 220Dexamethasone 205Fluorouracil 189fludarabine 178Oxaliplatin 177Pemetrexed 153Doxorubicin 152Irinotecan 147Etoposide 144Leucovorin 143Cytarabine 134fludarabine phosphate 129Bortezomib 129Cetuximab 127Lenalidomide 125Filgrastim 120Erlotinib Hydrochloride 119Temozolomide 111Ipilimumab 111

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Interventional × Human Papillomavirus Recombinant Vaccine nonavalent × Clear all
NCT03051516 2024-02-28

HPV Vaccine Therapy in Interrupting Progression in Patients With High-Grade Vulvar or Anal Lesions

Fred Hutchinson Cancer Center

Phase 4 Terminated
188 enrolled 13 charts
GastrointestinalGynecologic

High Grade Anal Canal Intraepithelial Neoplasia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡